-
1
-
-
0027447078
-
Xanthine derivatives: Comparison between suppression of tumor necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity
-
Semmler J, Gebert U, Eisenhut T, Moeller J, Schonharting MM, Allera A, et al. Xanthine derivatives: comparison between suppression of tumor necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity. Immunology 1993; 78: 520-5
-
(1993)
Immunology
, vol.78
, pp. 520-525
-
-
Semmler, J.1
Gebert, U.2
Eisenhut, T.3
Moeller, J.4
Schonharting, M.M.5
Allera, A.6
-
2
-
-
0026344142
-
Pentoxifylline suppression of tumor necrosis factor gene transcription
-
Doherty GM, Jensen JC, Alexander HR, Buresh CM, Norton JA. Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 1991; 110: 192-8
-
(1991)
Surgery
, vol.110
, pp. 192-198
-
-
Doherty, G.M.1
Jensen, J.C.2
Alexander, H.R.3
Buresh, C.M.4
Norton, J.A.5
-
3
-
-
0028302987
-
Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid
-
Rice GC, Brown PA, Nelson RJ, Bianco JA, Singer JW, Bursten S. Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid. Proc Natl Acad Sci USA 1994; 91: 3857-61
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 3857-3861
-
-
Rice, G.C.1
Brown, P.A.2
Nelson, R.J.3
Bianco, J.A.4
Singer, J.W.5
Bursten, S.6
-
4
-
-
0025998492
-
Phase I-II of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation
-
Bianco JA, Appelbaum FR, Nemunaitis J. Phase I-II of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood 1993; 78: 1205-11
-
(1993)
Blood
, vol.78
, pp. 1205-1211
-
-
Bianco, J.A.1
Appelbaum, F.R.2
Nemunaitis, J.3
-
5
-
-
0031962714
-
Effect of pentoxifylline in severe sepsis: Results of a randomized, double-blind, placebo-controlled study
-
Staubach KH, Schroder J, Stuber F, Gehrke K, Traumann E, Zabel P. Effect of pentoxifylline in severe sepsis: results of a randomized, double-blind, placebo-controlled study. Arch Surgery 1998; 133: 94-100
-
(1998)
Arch Surgery
, vol.133
, pp. 94-100
-
-
Staubach, K.H.1
Schroder, J.2
Stuber, F.3
Gehrke, K.4
Traumann, E.5
Zabel, P.6
-
6
-
-
0030997420
-
Effects of pentoxifylline on hemodynamics and oxygenation in septic and non-septic patients
-
Bacher A, Mayer N, Klimschka W, Oismuller C, Steltzer H, Hammerle A. Effects of pentoxifylline on hemodynamics and oxygenation in septic and non-septic patients. Crit Care Med 1997; 25: 795-800
-
(1997)
Crit Care Med
, vol.25
, pp. 795-800
-
-
Bacher, A.1
Mayer, N.2
Klimschka, W.3
Oismuller, C.4
Steltzer, H.5
Hammerle, A.6
-
7
-
-
0032041781
-
Pentoxifylline decreases the incidence of multiple organ failure in patients after major cardio-thoracic surgery
-
Hoffmann H, Markewitz A, Kreuzer E, Reichert A, Jochum M, Faist E. Pentoxifylline decreases the incidence of multiple organ failure in patients after major cardio-thoracic surgery. Shock 1998; 19: 234-40
-
(1998)
Shock
, vol.19
, pp. 234-240
-
-
Hoffmann, H.1
Markewitz, A.2
Kreuzer, E.3
Reichert, A.4
Jochum, M.5
Faist, E.6
-
8
-
-
0034776922
-
Pentoxifylline in perforated peritonitis: Results of a randomised, placebo controlled trial
-
Shukla VK, Ojha AK, Pandey M, Pandey BL. Pentoxifylline in perforated peritonitis: results of a randomised, placebo controlled trial. Eur J Surg 2001; 8: 622-4
-
(2001)
Eur J Surg
, vol.8
, pp. 622-624
-
-
Shukla, V.K.1
Ojha, A.K.2
Pandey, M.3
Pandey, B.L.4
-
9
-
-
9244247665
-
Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis
-
Lauterbach R, Zembala M. Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis. Eur J Pediatr 1996; 155: 404-9
-
(1996)
Eur J Pediatr
, vol.155
, pp. 404-409
-
-
Lauterbach, R.1
Zembala, M.2
-
10
-
-
0032916980
-
Effect of the immunomodulating agent, pentoxifylline in the treatment of sepsis in premature delivered infants: A placebo-controlled, double blind trial
-
Lauterbach R, Pawlik D, Kowalczyk D, Ksyciński W, Helwich E, Zembala M. Effect of the immunomodulating agent, pentoxifylline in the treatment of sepsis in premature delivered infants: a placebo-controlled, double blind trial. Crit Care Med 1999; 27: 807-14
-
(1999)
Crit Care Med
, vol.27
, pp. 807-814
-
-
Lauterbach, R.1
Pawlik, D.2
Kowalczyk, D.3
Ksyciński, W.4
Helwich, E.5
Zembala, M.6
-
11
-
-
0031424444
-
Serum concentrations of pentoxifylline and its metabolites in premature infants with sepsis when administered by continuous intravenous infusion
-
Szymura-Oleksiak J, Bury J, Lauterbach R, Pawłowski M. Serum concentrations of pentoxifylline and its metabolites in premature infants with sepsis when administered by continuous intravenous infusion. Pharmaceutical Sciences 1997; 3: 367-71
-
(1997)
Pharmaceutical Sciences
, vol.3
, pp. 367-371
-
-
Szymura-Oleksiak, J.1
Bury, J.2
Lauterbach, R.3
Pawłowski, M.4
-
12
-
-
9044224023
-
Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: Results from a double-blind, randomized, placebo-controlled study
-
Zeni F, Pain P, Vindimian M, Gay JP, Gery P, Bertrand M, Page Y, et al. Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study. Crit Care Med 1996; 24: 207-14
-
(1996)
Crit Care Med
, vol.24
, pp. 207-214
-
-
Zeni, F.1
Pain, P.2
Vindimian, M.3
Gay, J.P.4
Gery, P.5
Bertrand, M.6
Page, Y.7
-
13
-
-
0028808117
-
Role of elevated plasma soluble ICAM-1 and bronchial lavage fluid IL-8 levels as markers of chronic lung disease in premature infants
-
Little S, Dean T, Bevin S, Hall M, Asthon M, Church M, et al. Role of elevated plasma soluble ICAM-1 and bronchial lavage fluid IL-8 levels as markers of chronic lung disease in premature infants. Thorax 1995; 50: 1073-9
-
(1995)
Thorax
, vol.50
, pp. 1073-1079
-
-
Little, S.1
Dean, T.2
Bevin, S.3
Hall, M.4
Asthon, M.5
Church, M.6
-
14
-
-
0032945865
-
The differential effect of pentoxifylline on cytokine production by alveolar macrophages and its clinical implications
-
Poulakis N, Androutsos G, Kazi D, Bastas A, Provata A, Bitsakou C et al. The differential effect of pentoxifylline on cytokine production by alveolar macrophages and its clinical implications. Respir Med 1999; 93: 52
-
(1999)
Respir Med
, vol.93
, pp. 52
-
-
Poulakis, N.1
Androutsos, G.2
Kazi, D.3
Bastas, A.4
Provata, A.5
Bitsakou, C.6
-
15
-
-
0031060544
-
Anti-inflammatory and antifibrotic properties of colchicine: Implications for idiopathic pulmonary fibrosis
-
Entzian P, Schlaak M, Seitzer U, Bufe A, Acil Y, Zabel P. Anti-inflammatory and antifibrotic properties of colchicine: implications for idiopathic pulmonary fibrosis. Lung 1997; 175: 41-51
-
(1997)
Lung
, vol.175
, pp. 41-51
-
-
Entzian, P.1
Schlaak, M.2
Seitzer, U.3
Bufe, A.4
Acil, Y.5
Zabel, P.6
-
16
-
-
0033062634
-
Nebulized pentoxifylline in successful treatment of five premature neonates with bronchopulmonary dysplasia
-
Lauterbach R, Szymura-Oleksiak J. Nebulized pentoxifylline in successful treatment of five premature neonates with bronchopulmonary dysplasia. Eur J Pediatr 1999; 158: 607
-
(1999)
Eur J Pediatr
, vol.158
, pp. 607
-
-
Lauterbach, R.1
Szymura-Oleksiak, J.2
|